2007
DOI: 10.1159/000107103
|View full text |Cite
|
Sign up to set email alerts
|

Three Different Bradycardic Agents, Zatebradine, Diltiazem and Propranolol, Distinctly Modify Heart Rate Variability and QT-Interval Variability

Abstract: Zatebradine, diltiazem and propranolol are all antiarrhythmic agents, and all induce bradycardia, but each is known to have a different initial molecular mechanism: zatebradine is a channel blocker of the hyperpolarization-activated inward current (If ); diltiazem is a blocker of the L-type Ca2+ channel (ICaL), and propranolol is a β-blocker. To further investigate the mechanisms underlying their clinical effects, we studied their effects on heart rate variability (HRV) and QT-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 81 publications
0
7
0
Order By: Relevance
“…The mechanisms underlying the interactions between BVR and LF patterning of APD in response to sympathetic provocation (SP) and its potential link to arrhythmogenesis remain to be investigated. Regarding BVR, a growing number of studies, both experimental and computational, have provided evidence on the role of ion channel stochasticity and Ca 2+ cycling variations as underlying mechanisms of temporal variability at different scales, covering from isolated cells (Lemay et al, 2011; Pueyo et al, 2011, 2016a; Antoons et al, 2015; Kistamas et al, 2015; Nánási et al, 2017) to coupled cells / tissue (Zaniboni et al, 2000; Pueyo et al, 2011; Lemay et al, 2011; Magyar et al, 2015; Nánási et al, 2017) to whole heart (Yamabe et al, 2007; Baumert et al, 2016). Furthermore, the action of adrenergic stimulation in modulating those BVR mechanisms and facilitating arrhythmia initiation by the formation of afterdepolarizations and triggered activity has been reported in single cells (Johnson et al, 2010, 2013; Heijman et al, 2013; Szentandrássy et al, 2015; Hegyi et al, 2018) and in the whole heart (Gallacher et al, 2007).…”
Section: Background and Objectivesmentioning
confidence: 99%
“…The mechanisms underlying the interactions between BVR and LF patterning of APD in response to sympathetic provocation (SP) and its potential link to arrhythmogenesis remain to be investigated. Regarding BVR, a growing number of studies, both experimental and computational, have provided evidence on the role of ion channel stochasticity and Ca 2+ cycling variations as underlying mechanisms of temporal variability at different scales, covering from isolated cells (Lemay et al, 2011; Pueyo et al, 2011, 2016a; Antoons et al, 2015; Kistamas et al, 2015; Nánási et al, 2017) to coupled cells / tissue (Zaniboni et al, 2000; Pueyo et al, 2011; Lemay et al, 2011; Magyar et al, 2015; Nánási et al, 2017) to whole heart (Yamabe et al, 2007; Baumert et al, 2016). Furthermore, the action of adrenergic stimulation in modulating those BVR mechanisms and facilitating arrhythmia initiation by the formation of afterdepolarizations and triggered activity has been reported in single cells (Johnson et al, 2010, 2013; Heijman et al, 2013; Szentandrássy et al, 2015; Hegyi et al, 2018) and in the whole heart (Gallacher et al, 2007).…”
Section: Background and Objectivesmentioning
confidence: 99%
“…Ivabradine (20 mg/kg/d) administration significantly reduced the HR, but did not have hypoglycemic or weight loss effects (Figures 5A-C). On the basis of previous publications (Stieber et al, 2006;Yamabe et al, 2007), we administered 5, 10, or 20 mg/kg/day zatebradine and determined the effects on the HR of the mice. We found that 10 mg/kg/day zatebradine had the same HR-reducing effect as 20 mg/kg/day ivabradine FIGURE 6 | Ivabradine reduces JNK and p38 MAPK activation and inhibits diabetes-induced CF proliferation and activation in vivo (A) Left ventricular fibroblasts isolated from mice treated with ivabradine at the indicated dose.…”
Section: Resultsmentioning
confidence: 99%
“…Unfortunately, we could not provide enough data to illustrate these two contrary views. Because several classes of ion channels including the T-type Ca 2+ channels, most are the Cav3.1 and less are the Cav3.2 but not the Cav3.3 [ 6 ], contribute to pacemaker activity in the heart [ 31 , 32 , 33 ], the upregulation of Cav3-T-type Ca 2+ channels by BDNF lend support to the view that BDNF contributes to cardiac pacing activities. Interestingly, BDNF increases T-type Ca 2+ channel current as a short-term effect in sensory neurons via PI3K pathway [ 34 ], whereas the T-type Ca 2+ channel was not stimulated by BDNF in chick nodose neurons [ 35 , 36 ].…”
Section: Discussionmentioning
confidence: 99%